Total Pageviews

Tuesday, 1 November 2011

A New Tool for Targeted Cancer Drug Development

Source: Fox Chase Cancer (FCC) Center

FCCC has identified several drug candidates that have the ability to de-catalyze
the activity of the bio-catalysts critical for cancer and other diseases while seeking
to avoid major side effects.
FCC says that the results of this study will appear in the November issue of
Nature Biotechnology.......Read more